Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Guibin Qiao"'
Early patient‐reported outcomes after robotic‐assisted versus video‐assisted thoracoscopic lobectomy
Autor:
Zihua Lan, Cheng Zeng, Zijie Li, Xin Xia, Aotian Mo, Xianglin Li, Xiaosong Ben, Haiyu Zhou, Cheng Deng, Rixin Chen, Qiuling Shi, Yong Tang, Guibin Qiao
Publikováno v:
Thoracic Cancer, Vol 15, Iss 20, Pp 1563-1571 (2024)
Abstract Background Robotic‐assisted thoracoscopic surgery (RATS) can achieve traditional clinical outcomes comparable to those of video‐assisted thoracoscopic surgery (VATS). However, patient‐reported outcomes (PROs) during the early period af
Externí odkaz:
https://doaj.org/article/17160f71fd1a4c0e9e9b9979f7bcad35
Autor:
Xuefeng Sun, Zihua Lan, Shaopeng Li, Shujie Huang, Cheng Zeng, Junhan Wu, Qibin Chen, Yizhang Chen, Ziguo Chen, Yong Tang, Guibin Qiao
Publikováno v:
Thoracic Cancer, Vol 14, Iss 36, Pp 3503-3510 (2023)
Abstract Background Persistent cough is one of the most frequent complications following lung cancer surgery. To promote optimal recovery, we conducted a study to investigate the trajectories of coughing symptoms and their impact on quality of life (
Externí odkaz:
https://doaj.org/article/362f30c548b84c1ebdf3a58c02bd995b
Autor:
Jian‐Hua Liu, Ju‐Ze Lin, Qianhui Qiu, Changbin Zhu, Weiwei Li, Qian Li, Zhan Huang, Xueer Xia, Guibin Qiao, Jiming Tang
Publikováno v:
Thoracic Cancer, Vol 14, Iss 14, Pp 1294-1305 (2023)
Abstract Background The use of neoadjuvant immunotherapy plus chemotherapy has revolutionized the management of esophageal squamous cell carcinoma (ESCC) patients. Nevertheless, patients who would maximally benefit from these therapies have not been
Externí odkaz:
https://doaj.org/article/c681290086f2477bae9ae8012a8b3e09
Autor:
Bin Xu, Lan Liu, Shaowei Wu, Guangyi Wang, Guibin Qiao, Weijie Zhan, Daipeng Xie, Lintong Yao, Henian Yao, Guoqing Liao, Luyu Huang, Yubo Zhou, Peimeng You, Zekai Huang, Qiaxuan Li, Siyun Wang, Dong-Kun Zhang, Lawrence Wing-Chi Chan, Michael Lanuti, Haiyu Zhou
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 10 (2023)
Background The predictive efficacy of current biomarker of immune checkpoint inhibitors (ICIs) is not sufficient. This study investigated the causality between radiomic biomarkers and immunotherapy response status in patients with stage IB–IV non-s
Externí odkaz:
https://doaj.org/article/11ea3475d19b49ab8ececbeb1a429d48
Autor:
Min Ma, Liang Li, Shu-Han Yang, Chuan Huang, Weitao Zhuang, Shujie Huang, Xin Xia, Yong Tang, Zijun Li, Zhi-Bin Zhao, Qingyun Chen, Guibin Qiao, Zhe-Xiong Lian
Publikováno v:
OncoImmunology, Vol 13, Iss 1 (2024)
ABSTRACTRegulatory T (Treg) cells are critical in shaping an immunosuppressive microenvironment to favor tumor progression and resistance to therapies. However, the heterogeneity and function of Treg cells in esophageal squamous cell carcinoma (ESCC)
Externí odkaz:
https://doaj.org/article/f5ed722987764aa5a7ce1a11d994c17c
Autor:
Wei Gong, Yinyan Li, Jianfeng Xian, Lei Yang, Yuanyuan Wang, Xin Zhang, Yifeng Zhou, Xinhua Wang, Guibin Qiao, Cuiyi Chen, Soham Datta, Xincheng Gao, Jiachun Lu, Fuman Qiu
Publikováno v:
Cancer Cell International, Vol 22, Iss 1, Pp 1-16 (2022)
Abstract Background Long noncoding RNAs (lncRNAs) are emerging as master regulators for gene expression and thus play a vital role in human tumorigenesis and progression. But the involvement of novel lncRNAs in non-small cell lung cancer (NSCLC) rema
Externí odkaz:
https://doaj.org/article/21c2cd5f779c4978b4975551edcc79a3
Autor:
Weitao Zhuang, Hansheng Wu, Rixin Chen, Xiaosong Ben, Shujie Huang, Zihao Zhou, Junhan Wu, Yong Tang, Guibin Qiao
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundLymphovascular invasion (LVI) is recognized as an unfavorable prognostic factor for many solid tumors. However, its staging value has not been adequately illustrated in esophageal squamous cell carcinoma (ESCC).MethodsThe clinicopathologic
Externí odkaz:
https://doaj.org/article/333fb8abd3a34693a056880163c68c87
Autor:
Hansheng Wu, Haijie Xu, Shujie Huang, Yong Tang, Jiming Tang, Haiyu Zhou, Liang Xie, Guibin Qiao
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundLung adenocarcinoma (LUAD), the most common type of lung cancer, poses a significant threat to the life of patients. N6-methyladenosine modification is the most abundant epigenetic modification and may play an important role in the lung car
Externí odkaz:
https://doaj.org/article/9c46fb946ffb404b9280c1902178a971
Autor:
Yong Tang, Yadan Li, Lei Zhang, Guihui Tong, Zhu'an Ou, Zhuocai Wang, Henghui Zhang, Guibin Qiao
Publikováno v:
Thoracic Cancer, Vol 11, Iss 4, Pp 1094-1098 (2020)
Abstract Anti‐programmed cell death 1 (PD‐1) and its ligand (PD‐L1) has emerged as a novel immunotherapy for non‐small cell lung cancer (NSCLC). However, the proportion of patients who may benefit from immunotherapy is limited and the factors
Externí odkaz:
https://doaj.org/article/96ffb34636e54fd9851ae07bae8dc0fd
Autor:
Hongyuan Zhu, Daipeng Xie, Yunfang Yu, Lintong Yao, Bin Xu, Luyu Huang, Shaowei Wu, Fasheng Li, Yating Zheng, Xinyi Liu, Wenzhuan Xie, Mengli Huang, Hao Li, Shaopeng Zheng, Dongkun Zhang, Guibin Qiao, Lawrence W. C. Chan, Haiyu Zhou
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeThe KEAP1-NFE2L2 (Kelch-like ECH-associated protein 1 (KEAP1)-Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2)) mutations are associated with resistance to chemotherapy or immunotherapy in non-small cell lung cancer (NSCLC). Conversely, it
Externí odkaz:
https://doaj.org/article/14f46ce745294216873daeea1119f9a6